Kestra Medical Technologies Stock Performance
| KMTS Stock | 22.85 0.13 0.57% |
The company secures a Beta (Market Risk) of 1.68, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kestra Medical will likely underperform. At this point, Kestra Medical Techn has a negative expected return of -0.19%. Please make sure to verify Kestra Medical's downside variance, as well as the relationship between the daily balance of power and period momentum indicator , to decide if Kestra Medical Techn performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Kestra Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return (0.57) | Five Day Return (5.58) | Year To Date Return (6.31) | Ten Year Return 4.62 | All Time Return 4.62 |
1 | Why retail investors favor Kestra Medical Technologies Ltd. stock - Market Activity Recap Daily Stock Trend Watchlist - newser.com | 10/24/2025 |
2 | Kestra Medical Technologies Assessing a 20x Sales Valuation After a Recent Double-Digit Daily Gain | 12/04/2025 |
3 | Earnings To Watch Kestra Medical Technologies Ltd Reports Q2 2025 Result | 12/10/2025 |
4 | Kestra raises FY26 revenue guidance to 91M while targeting 70 gross margins with ASSURE system expansion | 12/12/2025 |
5 | Will Kestra Medical Technologies Ltd. stock benefit from AI adoption - Options Play Daily Momentum Trading Reports - | 12/18/2025 |
6 | Disposition of 15000 shares by Brian Webster of Kestra Medical at 26.5898 subject to Rule 16b-3 | 12/29/2025 |
7 | Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference | 12/30/2025 |
8 | Brokerages Set Kestra Medical Technologies, Ltd. Price Target at 29.14 | 01/05/2026 |
9 | Kestra, Biobeat partner to expand wearable defibrillator capabilities | 01/13/2026 |
| Begin Period Cash Flow | 8.6 M | |
| Total Cashflows From Investing Activities | -23.3 M |
Kestra Medical Relative Risk vs. Return Landscape
If you would invest 2,685 in Kestra Medical Technologies on October 20, 2025 and sell it today you would lose (400.00) from holding Kestra Medical Technologies or give up 14.9% of portfolio value over 90 days. Kestra Medical Technologies is currently does not generate positive expected returns and assumes 3.564% risk (volatility on return distribution) over the 90 days horizon. In different words, 31% of stocks are less volatile than Kestra, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Kestra Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kestra Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kestra Medical Technologies, and traders can use it to determine the average amount a Kestra Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0541
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KMTS |
Based on monthly moving average Kestra Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kestra Medical by adding Kestra Medical to a well-diversified portfolio.
Kestra Medical Fundamentals Growth
Kestra Stock prices reflect investors' perceptions of the future prospects and financial health of Kestra Medical, and Kestra Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kestra Stock performance.
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.44 | ||||
| Profit Margin | (1.78) % | ||||
| Operating Margin | (1.41) % | ||||
| Current Valuation | 1.36 B | ||||
| Shares Outstanding | 58.35 M | ||||
| Price To Book | 9.09 X | ||||
| Price To Sales | 20.07 X | ||||
| Revenue | 59.81 M | ||||
| Gross Profit | 34.46 M | ||||
| EBITDA | (97.98 M) | ||||
| Net Income | (113.81 M) | ||||
| Total Debt | 44.31 M | ||||
| Book Value Per Share | 3.19 X | ||||
| Cash Flow From Operations | (77.61 M) | ||||
| Earnings Per Share | (3.96) X | ||||
| Market Capitalization | 1.49 B | ||||
| Total Asset | 295.74 M | ||||
| Retained Earnings | (520.25 M) | ||||
| Working Capital | 217.35 M | ||||
About Kestra Medical Performance
Assessing Kestra Medical's fundamental ratios provides investors with valuable insights into Kestra Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Kestra Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 60.63 | 40.88 | |
| Return On Tangible Assets | (0.35) | (0.36) | |
| Return On Capital Employed | (0.37) | (0.39) | |
| Return On Assets | (0.35) | (0.36) | |
| Return On Equity | (0.50) | (0.52) |
Things to note about Kestra Medical Techn performance evaluation
Checking the ongoing alerts about Kestra Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kestra Medical Techn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kestra Medical Techn generated a negative expected return over the last 90 days | |
| Kestra Medical Techn has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 59.81 M. Net Loss for the year was (113.81 M) with profit before overhead, payroll, taxes, and interest of 34.46 M. | |
| Kestra Medical generates negative cash flow from operations | |
| Over 85.0% of the company shares are owned by institutional investors | |
| Latest headline from massdevice.com: Kestra, Biobeat partner to expand wearable defibrillator capabilities |
- Analyzing Kestra Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kestra Medical's stock is overvalued or undervalued compared to its peers.
- Examining Kestra Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kestra Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kestra Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kestra Medical's stock. These opinions can provide insight into Kestra Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.